Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Summary: In the last two decade, the world of interventional cardiology grew very much in various directions. In the same period , the scientific community has been attempting to shed light on whether the disparity in clinical presentation and response to treatment for many cardiovascular diseases in men and women were due to variations in biological pattern or to social and cultural conventions leading to different attitudes of doctors and patients toward cardiac diseases. Since the first percutaneous interventions in the cardiovascular system, it was observed that women experienced more procedural complications such as arterial dissections, bleedings, spasms etc. This raised the question of whether this is due to late presentation and mismanagement or to a different arterial disease pathophysiology.
It is now well known that compared to their male counterparts, women diagnosed with cardiovascular diseases are older, present more frequently with comorbidities such as diabetes, hypertension, renal insufficiency, inflammatory diseases, have more physical and cardiac dysfunction as well as a lower overall quality of life.
The book does not look within the word of percutaneous cardiovascular interventions to see if and which are the differences in the treatment or/and in the results but rather raise attention on specific points. For example:1) in the percutaneous treatment of Acute Myocardial Infarction, particularly in young women, where more often the disease is due to coronary dissection instead of atherosclerotic plaque rupture, more careful manipulations of guidewires or extensive stenting is needed.2) in carotid stenting, the smaller vessel and the facility to dissect make the procedure more risky and more demanding than in the male population.3) in the use of peri and post procedural antithrombotic therapy, the bleeding risk is higher, particularly when a triple therapy (two antiplatelets and an anticoagulant) is required.4) in transcatheter aortic valve implantation where differences are found both in pathology (higher transvalvular gradients, smaller aortic anulus, smaller LV cavity, more Left ventricular hypertrophy) and in the complications more anular rupture and peripheral vascular complications, less residual aortic regurgitations).5) furthermore there are diseases, which require catheter interventions, which are present much more frequently in women like mitral stenosis or tricuspid regurgitations.6) finally there is a condition unique to women, pregnancy, that, fortunately rarely, can require catheter intervention.
As Prof Serruys said "The development of a highly specialized subspecialty requires an in-depth knowledge of very specific details to efficiently and safely perform these interventions". As such, this book is aimed at providing some of these details in order to help the interventionalists to improve their approach and outcomes in the female population.
Endorsement: This document is endorsed by the European Association of Percutaneous Cardiovascular Interventions
Summary: The increasing interest in left atrial appendage occlusion (LAAO) for ischaemic stroke prevention in atrial fibrillation (AF) fuels the need for more clinical data on the safety and effectiveness of this therapy. Besides an assessment of the effectiveness of the therapy in specific patient groups, comparisons with pharmacological stroke prophylaxis, surgical approaches and other device-based therapies are warranted. This paper documents the consensus reached among clinical experts in relevant disciplines from Europe and North America, European cardiology professional societies and representatives from the medical device industry regarding definitions for parameters and endpoints to be assessed in clinical studies. Adherence to these definitions is proposed in order to achieve a consistent approach across clinical studies on LAAO among the involved stakeholders and various clinical disciplines and thereby facilitate continued evaluation of therapeutic strategies available.
Endorsement: This document is endorsed by the European Association of Percutaneous Cardiovascular Interventions, the European Heart Rhythm Association, the European Cardiac Arrhythmia Society, the Atrial Fibrillation Competence Network, and the Institut für Herzinfarktforschung Foundation.
Read the full text
Edited by Javier Escaned, MD, PhD and Patrick W. Serruys, MD, PhD
Coronary stenosis, Imaging, Structure and Physiology has become an important reference textbook for all those interested in the assessment and treatment of diseases affecting coronary circulation. The fully illustrated new online edition contains 50 chapters, including 10 updated and 17 new chapters. Learn more and purchase the Coronary Stenosis Textbook now.
For more information, please contact: email@example.com
The comprehensive visual reference for TAVI procedures, the Valve Atlas iPad app is a practical, dynamic educational tool designed for operators of all levels of experience. Embracing all facets of transcatheter aortic valve therapies, the app is fully enhanced with multimedia content. Download the Valve Atlas app now on the App Store.
© 2017 European Society of Cardiology. All rights reserved